NCT01830816 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 41
- units
- Participants
- groups
- description
- Ixazomib 3.0 mg, capsule, orally on Day 1 of Part A (15-day PK cycle) and on Days 1, 8, and 15 of each 28-day cycle in Part B (4.0, 3.0, or 2.3 mg per protocol) until disease progression or unacceptable toxicity.
- id
- BG000
- title
- Normal Renal Function: Ixazomib
- description
- Ixazomib 3.0 mg, capsule, orally on Day 1 of Part A (15-day PK cycle) and on Days 1, 8, and 15 of each 28-day cycle in Part B (4.0, 3.0, or 2.3 mg per protocol) until disease progression or unacceptable toxicity.
- id
- BG001
- title
- Severe Renal Impairment: Ixazomib
- description
- Ixazomib 3.0 mg, capsule, orally on Day 1 of Part A (15-day PK cycle) and on Days 1, 8, and 15 of each 28-day cycle in Part B (4.0, 3.0, or 2.3 mg per protocol) until disease progression or unacceptable toxicity.
- id
- BG002
- title
- End-stage Renal Disease: Ixazomib
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.01
- value
- 54.5
- group Id
- BG001
- spread
- 7.35
- value
- 72.1
- group Id
- BG002
- spread
- 12.65
- value
- 61.3
- group Id
- BG003
- spread
- 12.01
- value
- 61.7
- denoms
- counts
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 41
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 25
- title
- Female
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 16
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 41
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 4
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 35
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- title
- Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 41
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 13
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 27
- title
- White
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 12
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- title
- Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 41
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.28
- value
- 173.2
- group Id
- BG001
- spread
- 8.49
- value
- 160.8
- group Id
- BG002
- spread
- 9.61
- value
- 160.3
- group Id
- BG003
- spread
- 11.76
- value
- 167.1
- denoms
- counts
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 39
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- Number analyzed is the number of participants with data available for height.
- title
- Height
- unit Of Measure
- cm
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 27.66
- value
- 98.1
- group Id
- BG001
- spread
- 14.70
- value
- 60.7
- group Id
- BG002
- spread
- 27.11
- value
- 86.0
- group Id
- BG003
- spread
- 28.85
- value
- 83.3
- denoms
- counts
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 41
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Weight
- unit Of Measure
- kg
- population Description
- Safety population is defined as participants who received at least 1 dose of study drug.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 41
- units
- Participants
- groups
- description
- Ixazomib 3.0 mg, capsule, orally on Day 1 of Part A (15-day PK cycle) and on Days 1, 8, and 15 of each 28-day cycle in Part B (4.0, 3.0, or 2.3 mg per protocol) until disease progression or unacceptable toxicity.
- id
- BG000
- title
- Normal Renal Function: Ixazomib
- description
- Ixazomib 3.0 mg, capsule, orally on Day 1 of Part A (15-day PK cycle) and on Days 1, 8, and 15 of each 28-day cycle in Part B (4.0, 3.0, or 2.3 mg per protocol) until disease progression or unacceptable toxicity.
- id
- BG001
- title
- Severe Renal Impairment: Ixazomib
- description
- Ixazomib 3.0 mg, capsule, orally on Day 1 of Part A (15-day PK cycle) and on Days 1, 8, and 15 of each 28-day cycle in Part B (4.0, 3.0, or 2.3 mg per protocol) until disease progression or unacceptable toxicity.
- id
- BG002
- title
- End-stage Renal Disease: Ixazomib
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.01
- value
- 54.5
- group Id
- BG001
- spread
- 7.35
- value
- 72.1
- group Id
- BG002
- spread
- 12.65
- value
- 61.3
- group Id
- BG003
- spread
- 12.01
- value
- 61.7
- denoms
- counts
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 41
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 25
- title
- Female
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 16
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 41
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 4
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 35
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- title
- Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 41
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 13
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 27
- title
- White
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 12
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- title
- Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 41
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.28
- value
- 173.2
- group Id
- BG001
- spread
- 8.49
- value
- 160.8
- group Id
- BG002
- spread
- 9.61
- value
- 160.3
- group Id
- BG003
- spread
- 11.76
- value
- 167.1
- denoms
- counts
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 39
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- Number analyzed is the number of participants with data available for height.
- title
- Height
- unit Of Measure
- cm
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 27.66
- value
- 98.1
- group Id
- BG001
- spread
- 14.70
- value
- 60.7
- group Id
- BG002
- spread
- 27.11
- value
- 86.0
- group Id
- BG003
- spread
- 28.85
- value
- 83.3
- denoms
- counts
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 41
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Weight
- unit Of Measure
- kg
- population Description
- Safety population is defined as participants who received at least 1 dose of study drug.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle